Back

The Lancet Regional Health - Europe

32 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Spatiotemporal Trends in Suicide: Sociodemographic, Economic, and Environmental Factors
2026-03-05 epidemiology 10.64898/2026.03.04.26347568
#1 (1.9%)
Show abstract

Suicide is one of the worlds leading public health problems, with more than 720,000 deaths annually. Suicide has traditionally been studied from an individual perspective. However, research has increasingly highlighted the influence of community-level factors on suicide risk. This study aimed to (1) analyse the spatial distribution of suicide mortality at the provincial level in Spain (2018-2022); (2) perform stratified analyses by sex and age group; and (3) compare suicide risk across differen...

2
The Hidden Burden of Mortality Across the Spectrum of ICD-10 Conditions in Australia: A Multiple Cause of Death Analysis
2026-02-09 epidemiology 10.64898/2026.02.07.26345820
Top 0.1% (1.8%)
Show abstract

BackgroundDeath certificates record both an underlying cause and contributing conditions, yet mortality statistics predominantly report only the underlying cause. We quantify this "hidden burden" across all ICD-10 conditions in Australian mortality data using the multiple-to-underlying ratio (MUR): total death certificate mentions divided by underlying cause deaths. MethodsWe analysed Australian Bureau of Statistics Causes of Death 2023 data (N = 187,268 registered deaths) to compute the ratio ...

3
Secondary Prevention of Cardiovascular Events in Patients with Overweight/Obesity in Routine Clinical Practice
2026-02-20 epidemiology 10.64898/2026.02.18.26346594
Top 0.3% (1.5%)
Show abstract

Background and AimsThe glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide has demonstrated efficacy for the secondary prevention of cardiovascular disease among patients with overweight/obesity without diabetes mellitus. However, the comparative effectiveness of GLP-1 RA versus other antiobesity medications (e.g. phentermine-topiramate) not been evaluated. MethodsThis was a retrospective, observational, cohort study using target trial emulation methodology using the Truveta electro...

4
Assessing the impact of the COVID-19 pandemic on routine childhood vaccination uptake in the Netherlands
2026-02-20 epidemiology 10.64898/2026.02.19.26346601
Top 0.4% (1.4%)
Show abstract

BackgroundInitial reports from the Netherlands indicate a decline in routine childhood vaccination uptake during and after the COVID-19 pandemic, with emerging evidence of reduced parental vaccine confidence. This study aimed to evaluate the long-term impact of the COVID-19 pandemic on routine childhood vaccination uptake. MethodsWe conducted a retrospective nationwide cohort study including all children born in the Netherlands in 2016-2024. First-dose DTaP-IPV vaccination status by age six mon...

5
Trends in Cardiometabolic Disease and Health-Related Quality of Life in the United States, 2001-2022
2026-02-23 health economics 10.64898/2026.02.20.26346754
Top 0.4% (1.3%)
Show abstract

ObjectivesTo examine associations between cardiometabolic conditions and health-related quality of life (HRQoL) and to evaluate whether condition-associated HRQoL changed from 2001 to 2022. MethodsWe analyzed nationally representative data from U.S. adults aged [≥]18 years in the Medical Expenditure Panel Survey, 2001-2022. Survey years without BMI data (2017, 2019, 2021) were excluded. EQ-5D utilities were mapped from SF-12 scores using a validated algorithm. For each survey year, survey-we...

6
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes Mellitus
2026-02-24 endocrinology 10.64898/2026.02.23.26346890
Top 0.4% (1.3%)
Show abstract

BackgroundGLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2Is) have established cardiovascular benefits for patients with type 2 diabetes mellitus (T2DM), with similar class-level effectiveness found in previous studies. However, real-world comparative effectiveness assessments of individual agents remain limited. ObjectivesTo compare the cardiovascular effectiveness of individual GLP-1RAs and SGLT2Is. MethodsWe conducted a multi-national, retrospective, new-user active-comparator...

7
Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk
2026-02-17 public and global health 10.64898/2026.02.15.26346369
Top 0.5% (1.3%)
Show abstract

The biomarker MetaboHealth represents a novel indicator of overall health in middle age and may potentially be suitable as actionable health check in prevention strategies. MetaboHealth is a blood-based metabolomic composite score that predicts a wide range of age-related conditions and mortality in large European cohorts. Here, we investigated whether MetaboHealth can be personalised and limited to clinically validated metabolomic markers. Next, we assessed whether the updated MetaboHealth scor...

8
The age paradox in post-infectious sequelae: physiological reserve outweighs chronological age in Long COVID susceptibility
2026-02-26 public and global health 10.64898/2026.02.24.26346989
Top 0.5% (1.3%)
Show abstract

BackgroundOlder age is widely considered a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC), typically attributed to immunosenescence and inflammaging. However, whether this association reflects intrinsic biological ageing or accumulated comorbidity burden remains unclear, with implications for clinical risk stratification. MethodsWe conducted a retrospective cohort study using the Precision PASC Research Cohort (P2RC) from Mass General Brigham, comprising 133,792 COVID-19 pat...

9
Youth in crisis: comparative geographies of suicide between Argentina, Chile, Spain and Uruguay
2026-02-12 public and global health 10.64898/2026.02.06.26345682
Top 0.5% (1.3%)
Show abstract

IntroductionNational trends in youth suicide risk may mask significant regional variations within a country. This article attempts to account for spatio-temporal trends through a comparative analysis across South America and Europe. This paper analyzes the spatiotemporal patterns in suicide mortality among young people (10-29 years) in Argentina, Chile, Spain, and Uruguay during the period 1997-2021. MethodsOfficial data from vital statistics and population censuses of the four countries were a...

10
Monitoring influenza-like symptoms in the UK through participatory surveillance: insights from FluSurvey over two winter seasons (2023-24 and 2024-25)
2026-02-15 public and global health 10.64898/2026.02.12.26345150
Top 0.6% (1.3%)
Show abstract

FluSurvey is a participatory surveillance system used to monitor trends in influenza and other respiratory viruses through weekly symptom surveys among the UK population. We aimed to characterise the wider impact of "influenza-like illnesses" (ILI) among FluSurvey participants and assess correlations of ILI with other established influenza surveillance systems. We included data reported by FluSurvey participants over the 2023-24 and 2024-25 winter seasons. Using weekly symptoms surveys, we deri...

11
Continuous glucose monitor-derived glucotypes and cardiovascular risk scores in individuals without diabetes
2026-02-27 epidemiology 10.64898/2026.02.25.26347035
Top 0.6% (1.2%)
Show abstract

IntroductionDysglycemia is a well-established risk factor for cardiovascular disease (CVD); yet traditional glycemic traits, including fasting plasma glucose (FPG) and HbA1c, do not capture dynamic glucose fluctuations that may inform CVD risk. We cross-sectionally investigated the association of continuous glucose monitor (CGM)-derived metrics and 2-h post-prandial glucose (2-h PPG) with estimated 10-year CVD risk among individuals without diabetes. MethodsWe included 1,360 Framingham Heart St...

12
Economic burden of cancer and cardiovascular disease mortality among working-age Europeans: A lifecycle modelling study
2026-02-24 health economics 10.64898/2026.02.13.26346233
Top 0.7% (1.1%)
Show abstract

ObjectivesNon-communicable diseases (NCDs) account for almost 90% of deaths in Europe, yet comparative estimates of the productivity costs associated with premature NCD mortality across diseases and countries remain limited. This study estimates and compares productivity losses attributable to cardiovascular disease (CVD) and cancer mortality among working-age populations across Europe. Population-based data were used to estimate productivity costs for CVD and cancer deaths across 30 European co...

13
COVID-19 hospitalizations in the Netherlands, 2023-2024: disease burden and vaccine effectiveness
2026-02-16 epidemiology 10.64898/2026.02.12.26346177
Top 0.7% (1.1%)
Show abstract

Since the cessation of real-time monitoring of COVID-19 hospitalizations in early 2024, the burden of and vaccine effectiveness (VE) against severe COVID-19 in the Netherlands was largely unknown. Recently, hospitalization data from 2024 were made available for the purpose of monitoring and evaluating the COVID-19 vaccination campaigns. These data were linked to the population registry, vaccination registry and healthcare use data (for classification into medical risk groups). We analyzed the n...

14
Changes In Incidence And Serotype Distribution Of Pediat-Ric Invasive Pneumococcal Disease After The Introduction Of 15-Valent Pneumococcal Conjugate Vaccine In Catalo-Nia, Spain. A Multicenter Surveillance Study
2026-02-12 epidemiology 10.64898/2026.02.11.26346066
Top 0.7% (1.1%)
Show abstract

BackgroundSerotype 3 (S3) has remained a major cause of invasive pneumococcal disease (IPD) despite its inclusion in 13-valent pneumococcal conjugate vaccine (PCV). In October 2023, a 15-valent PCV (PCV15) including S3 was introduced into the Catalan universal childhood immunization program. MethodsWe conducted a retrospective pre-post surveillance study to compare pediatric IPD incidence in Catalonia during a pre-PCV15 period (October 1, 2022-September 30, 2023) and two post-PCV15 periods (Oct...

15
Cross-sectional and longitudinal associations between dietary intake and depressive symptoms in young South African adults: The African-PREDICT study
2026-02-15 nutrition 10.64898/2026.02.13.26346223
Top 1.0% (1.0%)
Show abstract

IntroductionDepression is highly prevalent among young adults worldwide. While research links health behaviours, such as dietary intake, to depression, few studies have examined these associations among young adults in low- and middle-income countries, including South Africa. This study investigated whether dietary intake was associated with an increased risk of depression in a cohort of young South African adults, aged 20-30 years, as part of the Global burden of disease Lifestyle And mental Di...

16
Eligibility Without Equity: Rethinking Age-Based Adult Vaccine Policies
2026-02-18 public and global health 10.64898/2026.02.17.26346473
Top 1% (0.9%)
Show abstract

Embedding equity into vaccine eligibility is essential for reducing health inequalities. Yet, adult vaccine eligibility in most European countries is primarily based on fixed age thresholds, prioritising cost-effectiveness. This approach risks excluding the most vulnerable populations living in deprived communities with poorer health and shorter survival into older age. Extending eligibility based on clinical risk partially addresses this gap. Higher rates of underdiagnosis and delayed diagnosis...

17
A longitudinal study of anxiety and depression in Belgium during and after the COVID-19 pandemic
2026-02-26 psychiatry and clinical psychology 10.64898/2026.02.24.26347039
Top 1% (0.9%)
Show abstract

BackgroundThe COVID-19 pandemic, coupled with concurrent social instabilities, has raised concerns about the long-term impact on the population mental health. While existing studies have primarily focused on the acute phase, less is known about how anxiety and depression symptoms have evolved throughout prolonged societal disruption. This study aimed to identify distinct anxiety and depression symptom trajectories and to determine the individual, relational, and societal protective and risk fact...

18
Acetate, a fibre-derived gut metabolite, and modification of hormone-related cardiovascular risk in females
2026-02-12 cardiovascular medicine 10.64898/2026.02.10.26346040
Top 1% (0.9%)
Show abstract

BackgroundSex hormone alterations, such as estrogen deficiency or testosterone excess, substantially increase cardiovascular disease (CVD) risk in females. Dietary fibre and its microbial by-products, short-chain fatty acids (SCFAs), have cardioprotective effects, but it remains unclear whether these benefits extend to females with an altered sex hormone profile. In this study, we aim to investigate whether dietary fibre intake, measured via plasma acetate--the most abundant SCFA--is associated ...

19
Trajectories of pain and cognitive function: 22 years of evidence in mid-to-later life
2026-02-11 epidemiology 10.64898/2026.02.10.26345971
Top 1% (0.9%)
Show abstract

Chronic pain has been identified as a risk factor for cognitive decline in later life. However, most studies measure pain at a single time point and none have investigated whether variations in pain severity are associated with changes in cognitive function over time. This project aimed to assess the relationship between individual-level change in pain severity and decline in cognitive function over time. We used data from the English Longitudinal Study of Ageing (ELSA), a cohort of nationally r...

20
Utility of glucose, lipid and kidney function Trajectory Measures for incident Cardiovascular Disease risk prediction for people living with Type 2 Diabetes: a case-study using Danish registry data
2026-03-06 cardiovascular medicine 10.64898/2026.03.06.26347493
Top 1% (0.9%)
Show abstract

Abstract Introduction Cardiovascular disease (CVD) is an important complication of type 2 diabetes (T2D). Current incident CVD-prediction models use single baseline measurements and achieve moderate performance in people with T2D, with C-indices around 0.7. Modern healthcare registries contain repeated measurements of HbA1c, LDL-cholesterol and eGFR, which could carry incremental predictive value. However, the added value of trajectory measures for CVD-risk prediction remains unclear. We aimed t...